EN DE
STOCK COMPARISON

Exa E&c vs Fischer Medical Ventures: Fair Value & Quality

Both stocks run through our valuation models. Here is how Exa E&c (054940) and Fischer Medical Ventures (FISCHER) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Exa E&c as the less overvalued of the two: Exa E&c trades at KRW 3,665 versus a fair value of KRW 830 (-77%), while Fischer Medical Ventures trades at ₹34.28 versus ₹4.55 (-87%).
Exa E&c
054940.KQ · KRW · Industrials
-77%
upside to fair value
overvalued
PriceKRW 3,665
Fair ValueKRW 830
Quality49/100
Fischer Medical Ventures
FISCHER.BSE · INR · Industrials
-87%
upside to fair value
overvalued
Price₹34.28
Fair Value₹4.55
Quality40/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Exa E&cFischer Medical Ventures
Valuation
n/aP/E (TTM)76.2×
n/aP/S (TTM)8.34×
n/aP/B6.69×
n/aEV/EBITDA62.8×
−77.4%Fair value upside−86.7%
n/aDividend yield0.1%
n/aDividend per share₹0.05
Profitability
7%Operating margin0%
4.67×EBIT margin trend (5Y)n/a
n/aReturn on equity9%
7%Return on assets4%
Growth
10%Revenue growth (YoY)99%
-7.9%Avg. growth/yr (3Y)1,097.9%
-5.5%Avg. growth/yr (5Y)351.2%
−56.2%Value creation/yr−44.1%
Balance & size
1.5×Interest coverage (EBIT/interest)6.9×
0.14×Debt / equity0.00×
n/aMarket cap$268M
weakGrowth qualitymixed

Fischer Medical Ventures leads: 3 to 6 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Exa E&cof which business quality 47 · market factors 40 Fischer Medical Venturesof which business quality 41 · market factors 27
ProfitabilityMargins and returns on capital today
33
37
Quality GrowthAre margins and returns improving?
15
89
CashflowEarnings quality: real cash, not paper profit
36
0
Fin. StrengthBalance sheet, leverage, solvency risk
49
77
InvestmentDisciplined investing over empire-building
87
50
Low VolatilityCalm price path (market factor)
30
57
MomentumPrice trend over the last 3–12 months (market factor)
44
21
52W MomentumDistance to the 52-week high (market factor)
44
2
Net IssuanceShare count: buybacks or dilution?
82
0

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyExa E&cPrice KRW 3,665Fischer Medical VenturesPrice ₹34.28
DCF Models-69%below the priceKRW 1,130-63%below the price₹12.84
Earnings-Based-86%below the priceKRW 508-52%below the price₹16.59
Dividend Discountn/a-100%below the price₹0.05
Multiples-75%below the priceKRW 921-75%below the price₹8.44
Asset-Based-62%below the priceKRW 1,392-89%below the price₹3.93
Growth DCF-72%below the priceKRW 1,023n/a
Economic Profit-71%below the priceKRW 1,069-87%below the price₹4.51
Growth Earnings-92%below the priceKRW 303-37%below the price₹21.70
Minimum-92%below the priceKRW 303-100%below the price₹0.05
Maximum-62%below the priceKRW 1,392-37%below the price₹21.70
Median-72%below the priceKRW 1,023-75%below the price₹8.44
Geometric mean-78%below the priceKRW 817-87%below the price₹4.45

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Exa E&c: 20 of 20 models see the stock below the current price.

Fischer Medical Ventures: 17 of 17 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Exa E&c
Price KRW 3,665
Fair Value KRW 830
Bear KRW 783Bull KRW 870
Fischer Medical Ventures
Price ₹34.28
Fair Value ₹4.55
Bear ₹3.39Bull ₹7.73

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Exa E&c · Industrials

Quality score49 · below median
Fair value upside-77% · bottom 25%

Fischer Medical Ventures · Industrials

Quality score40 · bottom 25%
Fair value upside-87% · bottom 25%

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Exa E&c as the less overvalued of the two: Exa E&c trades at KRW 3,665 versus a fair value of KRW 830 (-77%), while Fischer Medical Ventures trades at ₹34.28 versus ₹4.55 (-87%).

Exa E&c has the higher quality score (49/100).

Open Exa E&c live analysis →
Exa E&c · Fischer Medical Ventures

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Exa E&c

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Fischer Medical Ventures

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.